3 Firms Guide $1B Lilly Deal For ALS Drug Researcher
Eli Lilly said Tuesday it has reached a deal worth up to roughly $1 billion for ALS, Alzheimer's and other neurodegenerative disease treatment researcher Prevail in a deal led by Weil,...To view the full article, register now.
Already a subscriber? Click here to view full article